Skip to content

Feasibility Study of Biofeedback in Dysphagia Therapy Post Stroke

A Randomised Controlled Feasibility Trial of Dysphagia Therapy Using Biofeedback in Patients With Acute Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03499574
Enrollment
27
Registered
2018-04-17
Start date
2018-01-26
Completion date
2020-05-31
Last updated
2020-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia, Oropharyngeal, Stroke, Acute

Brief summary

This study will investigate the feasibility of delivering swallowing therapy using surface electromyography as a means of biofeedback to patients with dysphagia in the acute stroke setting. It will investigate trends in efficacy by comparing biofeedback therapy to usual care. The results will inform future dosing and efficacy studies.

Interventions

BEHAVIORALDysphagia therapy using surface EMG as biofeedback

10 x 45 minute sessions over 14 days

BEHAVIORALUsual Care

Usual care may include the following Speech and Language Therapy interventions; assessment, review, therapy, patient/family education etc.. Dose will vary.

Sponsors

National Institute for Health Research, United Kingdom
CollaboratorOTHER_GOV
University of Nottingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomised Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* New diagnosis stroke, new dysphagia, medically stable, adequate trunk strength for videofluoroscopy.

Exclusion criteria

* Severe cognitive impairment, previous dysphagia, previous neurological condition, severe visual impairment

Design outcomes

Primary

MeasureTime frameDescription
Number of participants recruited2 weeksCount of number of participants can be recruited
Number of participants completing the treatment2 weeksCount of number of participants completing the treatment
Average number of sessions completed2 weeksAverage number of sessions completed across participants.

Secondary

MeasureTime frameDescription
Change in swallow physiology - timingPre and post 2 week interventionVideofluoroscopy assessment to measure timing of swallow physiology
Quality of lifePre and post 2 week intervention and at 90 daysDysphagia Handicap Index
Change in Clinical outcomes - disabilityPre and post 2 week intervention and at 90 days.Disability - using the Modified Rankin scale. Scale from 0-6 with higher numbers signifying increased disability
Change in Swallow function - severityPre and post 3 week intervention intervention and at 90 daysUsing Dysphagia Severity Rating Scale - scale of 0-16. 0 is normal, 16 is the most severe.
Change in Clinical outcomes - tube statusPre and post 2 week intervention and at 90 days.Feeding tube status
Change in Clinical outcomes - mortalityPre and post 2 week intervention and at 90 days.Mortality
Change in Clinical outcomes - pneumoniaPre and post 2 week intervention and at 90 days.Presence of pneumonia
Change in Clinical outcomes - stroke severityPre and post 2 week interventionStroke severity - NIHSS. Scale from 0-42. Increased number means increase in stroke severity.
Change in Swallow function - intakePre and post 3 week intervention intervention and at 90 daysFunctional Oral Intake Scale - 7 point scale from 1-7. Higher number indicated increased amount and normality of oral intake.
Change in Swallow physiology - PASPre and post 2 week interventionVideofluoroscopy assessment to measure swallow safety with regards to penetration/aspiration using the Penetration Aspiration Scale (PAS). 8 point scale. The higher the number the increase in penetration/aspiration.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026